Atara Biotherapeutics (ATRA) Cash from Operations Growth (1y) (2014 - 2026)
Atara Biotherapeutics (ATRA) Cash from Operations Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,824.80 Bn | 1,824.74 Bn | - | - |
| 2 | Akari Therapeutics | 955.99 Bn | 955.99 Bn | - | - |
| 3 | BeOne Medicines | 473.90 Bn | 469.11 Bn | 1.35 Bn | 356.73% |
| 4 | Vertex Pharmaceuticals | 123.79 Bn | 116.54 Bn | 2.59 Bn | 74.39% |
| 5 | Regeneron Pharmaceuticals | 71.64 Bn | 62.88 Bn | 3.31 Bn | 3.23% |
| 6 | Belite Bio | 62.78 Bn | 62.78 Bn | - | - |
| 7 | Argenx Se | 55.45 Bn | 50.27 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn | 158.60% |
| 9 | Revolution Medicines | 37.16 Bn | 37.16 Bn | - | - |
| 10 | Atara Biotherapeutics | 109.27 Mn | 100.91 Mn | 392,000.00 | 89.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.08% |
| Dec 31, 2025 | 76.72% |
| Sep 30, 2025 | -145.35% |
| Jun 30, 2025 | 31.25% |
| Mar 31, 2025 | 4.98% |
| Dec 31, 2024 | 51.45% |
| Sep 30, 2024 | 92.23% |
| Jun 30, 2024 | 79.84% |
| Mar 31, 2024 | 22.94% |
| Dec 31, 2023 | 11.38% |
| Sep 30, 2023 | 21.08% |
| Jun 30, 2023 | 17.46% |
| Mar 31, 2023 | 54.54% |
| Dec 31, 2022 | -65.98% |
| Sep 30, 2022 | -10.31% |
| Jun 30, 2022 | -3.88% |
| Mar 31, 2022 | -28.66% |
| Dec 31, 2021 | -731.77% |
| Sep 30, 2021 | -11.37% |
| Jun 30, 2021 | -8.72% |